| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $104.3M | +162.4% | +810.2% |
| Cost of Revenue | $7.6M | +306.2% | +1002.0% |
| Gross Profit | $93.1M | +145.8% | +764.3% |
| R&D Expense | $5.1M | +108.7% | +601.1% |
| SG&A Expense | $25.5M | +167.8% | +286.7% |
| Operating Income | $51.3M | +162.7% | +1661.9% |
| Pre-tax Income | $52.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $48.5M | -69.6% | +37.4% |
| Short-term Investments | $7.2M | -77.0% | -32.8% |
| Accounts Receivable | $158.6M | +269.5% | +812.0% |
| Inventory | $28.9M | +200.1% | +334.9% |
| Current Assets | $259.5M | +4.6% | +254.8% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $80.6M | — | — |
| Capital Expenditures | $540K | — | — |
| Investing Cash Flow | -$311.7M | — | — |
| Financing Cash Flow | $239.9M | — | — |
| Free Cash Flow | $80.0M | — | — |
| +158.4% |
| +1993.4% |
| Income Tax | -$56.0M | — | — |
| Net Income | $108.6M | +447.5% | +4009.6% |
| EPS (Basic) | $1.42 | +389.7% | +2940.0% |
| EPS (Diluted) | $1.26 | +350.0% | +2620.0% |
| $750.9M |
| +197.3% |
| +867.8% |
| Current Liabilities | $133.6M | +321.4% | +623.1% |
| Total Liabilities | $376.7M | +1078.4% | +1896.0% |
| Stockholders' Equity | $374.1M | +69.6% | +537.2% |